MedTrace Logo

Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation

NCT02264249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 449

Last updated 2017-05-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine residual gastric volume and residual gastric pH in patients undergoing combined EGD and colonoscopy comparing the standard single dose prep with the split dose bowel preparation and same day bowel preparations.

Conditions

  • Esophagogastroduodenoscopy
  • Colonoscopy

Interventions

OTHER

Esophagogastroduodenoscopy and colonoscopy split dose prep

Patients undergoing a combined EGD (esophagogastroduodenoscopy) and a colonoscopy receive the Split dose colonoscopy prep split dose colonoscopy preparation- ½ evening before and ½ early AM (4L volume or 2L volume bowel preparation)

OTHER

Esophagogastroduodenoscopy and colonoscopy Evening before colonoscopy prep

Patients undergoing a combined EGD (esophagogastroduodenoscopy) and a colonoscopy receive Evening before (4L, 2L or miralax bowel preparation)

OTHER

Esophagogastroduodenoscopy and colonoscopy Same day prep colonoscopy preparation

Patients undergoing a combined EGD (esophagogastroduodenoscopy) and a colonoscopy receive Same day prep (4L volume or 2L volume or Miralax bowel preparation)

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Alison Schneider, M.D. · Cleveland Clinic Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-11-30
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02264249 on ClinicalTrials.gov